These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10229425)

  • 1. Clinimetric concepts in outcome assessment: the OMERACT filter.
    Bellamy N
    J Rheumatol; 1999 Apr; 26(4):948-50. PubMed ID: 10229425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT.
    van der Heijde D; Landewé R
    J Rheumatol; 2005 Oct; 32(10):2048-9. PubMed ID: 16206368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.
    Beaton DE; Maxwell LJ; Shea BJ; Wells GA; Boers M; Grosskleg S; Bingham CO; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March LM; Simon LS; Singh JA; Strand V; Tugwell P
    J Rheumatol; 2019 Aug; 46(8):1028-1035. PubMed ID: 30709952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
    van der Heijde DM; Landewé RB; Hermann KG; Jurik AG; Maksymowych WP; Rudwaleit M; O'Connor PJ; Braun J
    J Rheumatol; 2005 Oct; 32(10):2042-7. PubMed ID: 16206367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On.
    Bruyn GA; Iagnocco A; Naredo E; Balint PV; Gutierrez M; Hammer HB; Collado P; Filippou G; Schmidt WA; Jousse-Joulin S; Mandl P; Conaghan PG; Wakefield RJ; Keen HI; Terslev L; D'Agostino MA;
    J Rheumatol; 2019 Oct; 46(10):1388-1393. PubMed ID: 30709946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of ankylosing spondylitis.
    Zochling J; Braun J
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S133-41. PubMed ID: 16273797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example.
    Terslev L; Naredo E; Keen HI; Bruyn GAW; Iagnocco A; Wakefield RJ; Conaghan PG; Maxwell LJ; Beaton DE; Boers M; D'Agostino MA
    J Rheumatol; 2019 Oct; 46(10):1394-1400. PubMed ID: 30877208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity.
    Tugwell P; Boers M; D'Agostino MA; Beaton D; Boonen A; Bingham CO; Choy E; Conaghan PG; Dougados M; Duarte C; Furst DE; Guillemin F; Gossec L; Heiberg T; van der Heijde DM; Hewlett S; Kirwan JR; Kvien TK; Landewé RB; Mease PJ; Østergaard M; Simon L; Singh JA; Strand V; Wells G
    J Rheumatol; 2014 May; 41(5):1000-4. PubMed ID: 24692531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ankylosing spondylitis. Target treatment criteria].
    Braun J; Sieper J
    Z Rheumatol; 2009 Feb; 68(1):30-6. PubMed ID: 19145445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process.
    Kroon FPB; van der Heijde D; Maxwell LJ; Beaton DE; Abishek A; Berenbaum F; Blanco FJ; Conaghan PG; Dziedzic K; Hill CL; Haugen IK; Ishimori M; Ritschl V; Stamm TA; Wittoek R; Kloppenburg M
    Semin Arthritis Rheum; 2021 Dec; 51(6):1311-1319. PubMed ID: 34538514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV.
    van der Heijde D; van der Linden S; Bellamy N; Calin A; Dougados M; Khan MA
    J Rheumatol; 1999 Apr; 26(4):945-7. PubMed ID: 10229424
    [No Abstract]   [Full Text] [Related]  

  • 13. OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.
    Boers M; Beaton DE; Shea BJ; Maxwell LJ; Bartlett SJ; Bingham CO; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March L; Simon LS; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2019 Aug; 46(8):1021-1027. PubMed ID: 30770515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.
    van der Heijde D; Calin A; Dougados M; Khan MA; van der Linden S; Bellamy N
    J Rheumatol; 1999 Apr; 26(4):951-4. PubMed ID: 10229426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout.
    Taylor WJ; Redden D; Dalbeth N; Schumacher HR; Edwards NL; Simon LS; John MR; Essex MN; Watson DJ; Evans R; Rome K; Singh JA
    J Rheumatol; 2014 Mar; 41(3):574-80. PubMed ID: 24429178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2.
    Maxwell LJ; Beaton DE; Boers M; D'Agostino MA; Conaghan PG; Grosskleg S; Shea BJ; Bingham Iii CO; Boonen A; Christensen R; Choy E; Doria AS; Hill CL; Hofstetter C; Kroon FP; Leung YY; Mackie S; Meara A; Touma Z; Tugwell P; Wells GA
    Semin Arthritis Rheum; 2021 Dec; 51(6):1320-1330. PubMed ID: 34544617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop.
    Bingham CO; Alten R; Bartlett SJ; Bykerk VP; Brooks PM; Choy E; Christensen R; Furst DE; Hewlett SE; Leong A; May JE; Montie P; Pohl C; Sanderson TC; Strand V; Woodworth TG;
    J Rheumatol; 2011 Aug; 38(8):1751-8. PubMed ID: 21807797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domains selection for patient-reported outcomes: current activities and options for future methods.
    Tugwell PS; Petersson IF; Boers M; Gossec L; Kirwan JR; Rader T; Sanderson TC; van de Laar MA; Ueffing E; Witter JP
    J Rheumatol; 2011 Aug; 38(8):1702-10. PubMed ID: 21807789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing Stiffness Measurement in Rheumatic Disease: Report from the Stiffness Special Interest Group at OMERACT 2018.
    Craig ET; Orbai AM; Mackie S; Bartlett SJ; Bingham CO; Goodman S; Hill C; Holt R; Leong A; Karyekar C; Leung YY; Richards P; Halls S
    J Rheumatol; 2019 Oct; 46(10):1374-1378. PubMed ID: 30770511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
    Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
    J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.